MedifastMED -0.44%69 Current Ratio is 4.80 as of Mar. 2026, which is 98% above its 10-year median of 2.42. GuruFocus rates MED with a GF Score™ of 69/100 and a GF Value™ of $8.75 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 98 Personal Services companies, Medifast ranks better than 92.86% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Medifast's current ratio for the quarter that ended in Mar. 2026 was 4.80.
Medifast has a current ratio of 4.80. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Medifast's Current Ratio or its related term are showing as below:
MED'
s Current Ratio Range Over the Past 10 Years
Min: 1.29 Med: 2.42 Max: 4.8
Current: 4.8
During the past 13 years, Medifast's highest Current Ratio was 4.80. The lowest was 1.29. And the median was 2.42.
MED's Current Ratio is ranked better than 92.86% of 98
companies
in the Personal Services industry
Industry Median: 1.24
vs MED: 4.80
Medifast (NYSE:MED) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Medifast Current Ratio Related Terms
Medifast Current Ratio Historical Data
* Premium members only.
The historical data trend for Medifast's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Personal Services subindustry, Medifast's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast Current Ratio vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's Current Ratio distribution charts can be found below:
* The bar in red indicates where Medifast's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (MED) has a Current Ratio of 4.80 as of Mar. 2026. This is 98% above median its historical median of 2.42. Over the past decade, Medifast's Current Ratio has ranged from 1.29 to 4.80. According to the industry distribution chart, Medifast ranks #7 out of 98 companies in the Personal Services industry, placing it in the top 7.1%.
Is Medifast's Current Ratio too high?
Medifast's current Current Ratio of 4.80 is 98% above median its 10-year median of 2.42. Over the past 10 years, this metric has ranged from a low of 1.29 to a high of 4.80. The Personal Services industry median Current Ratio is 1.24. Medifast's value of 4.80 is 287.1% above this industry median. Based on the distribution chart, Medifast ranks #7 out of 98 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medifast has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Current Ratio compare to RGS and VGES?
According to the Personal Services industry distribution chart, Medifast ranks #7 out of 98 companies for Current Ratio. This places Medifast in the top 7% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.24. Medifast's value of 4.80 is 287.1% above this benchmark. Historically, Medifast's own Current Ratio has ranged from 1.29 to 4.80 over the past decade. While the company's 10-year median is 2.42 vs. the industry median of 1.24, Medifast has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Personal Services company?
The median Current Ratio among Personal Services companies is 1.24, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medifast's current Current Ratio of 4.80 is 287.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Personal Services industry, the median Current Ratio is 1.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current Current Ratio is 4.80, which is 98% above median its own 10-year median of 2.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (MED) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.75, compared to a current price of $10.16 — trading 16.1% above its estimated fair value. The current Current Ratio is 4.80, which is 98% above median its 10-year median of 2.42 and 287.1% above the Personal Services industry median of 1.24. Medifast's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Medifast (MED), the current Current Ratio is 4.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of $10.16 is trading 16.1% above its estimated GF Value™ of $8.75.
GuruFocus considers Medifast to be Modestly Overvalued.
Key valuation signals for MED:
Current Ratio: 4.80 (98% above median its 10-year median of 2.42)
GF Value™: $8.75 vs. price of $10.16 (16.1% above fair value)
Industry Position: 287.1% above the Personal Services median (#7 of 98)
No single metric tells the full story. See the MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
69GF Score
Get the complete analysis for MED
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MED has been successfully added to your 
